Barely two months after it agreed to a WTO deal for temporary intellectual property rights (IP) waiver for Covid vaccines, India has restarted its campaign to extend it to other Covid drugs, diagnostics and medical technologies.
Multiple officials told Moneycontrol that they remain confident of securing support from more nations this time around.
The IP waiver for vaccine production was agreed in a WTO meet in June this year, which decided that the trade body will revisit the issue of extending it to other treatments within six months ending December.
"The latest text focuses disproportionately on the use of the compulsory licensing system. This would allow governments to permit the manufacture of vaccines and other medicines without infringement of IP rights during an emergency such as a pandemic," an official said.